Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05240066 · ClinicalTrials.gov registry record
Birth Control to Improve Birth Spacing
A clinical trial of Contraception and Knowledge, Attitudes, Practice, sponsored by Brigham and Women's Hospital.
- Active
- Registry status
- 1,341
- Enrollment target
- 2
- Study locations
NCT05240066: Active study of Contraception and Knowledge, Attitudes, Practice, sponsored by Brigham and Women's Hospital.
NCT05240066 is a study of Contraception and Knowledge, Attitudes, Practice that is active but no longer recruiting, run by Brigham and Women's Hospital. The registered enrollment target is 1,341 participants, above the 436-participant average among 72 other Contraception trials with a reported enrollment target (208% higher). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05240066, a study of Contraception and Knowledge, Attitudes, Practice, is active but no longer recruiting, sponsored by Brigham and Women's Hospital.
- ACTIVE NOT RECRUITING
- Registry status
- 1,341 participants
- Enrollment target
- 2
- Study locations
Study Summary
This study aims to investigate the drivers of postpartum contraceptive use with a prospective cohort. The study will clarify the role of contraceptive knowledge, attitudes, norms, and self-efficacy in driving intention to initiate contraception postpartum and describe the impact of environmental barriers on enacting intended postpartum contraception initiation.
Primary Outcome
self-reported desire to space births
Conditions Studied
Study Locations (2)
Massachusetts
- Brigham and Women's Hospital - Boston
- Boston Medical Center - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,341 participants |
| Start Date | 2022-02-17 |
| Est. Completion | 2026-06-30 |
What the registry record for NCT05240066 still lists
NCT05240066 is an observational study that tracks outcomes without assigning an intervention. Its 1,341 participants enrollment target places it among the larger protocols in the corpus, above the 436-participant average among 72 other Contraception trials with a reported enrollment target (208% higher).
The record links to 4 conditions, with Contraception appearing as the primary indexed condition, and to 0 interventions.
NCT05240066 reports a single indexed study location in Massachusetts.
Frequently Asked Questions
What is clinical trial NCT05240066 about?
NCT05240066 is a clinical study titled "Birth Control to Improve Birth Spacing". This study aims to investigate the drivers of postpartum contraceptive use with a prospective cohort. The study will clarify the role of contraceptive knowledge, attitudes, norms, and self-efficacy in driving intention to initiate contraception postpartum and describe the impact of environmental bar...
What is the current status of trial NCT05240066?
This trial is currently active not recruiting. The enrollment target is 1,341 participants. The study started on 2022-02-17. Estimated completion is 2026-06-30.
What conditions does trial NCT05240066 study?
This clinical trial studies the following conditions: Contraception, Knowledge, Attitudes, Practice, Contraception Behavior, Birth Spacing.
Who is sponsoring clinical trial NCT05240066?
This trial is sponsored by Brigham and Women's Hospital, which has 937 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05240066 being conducted?
This trial has 2 study locations across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Contraception
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05240066's enrollment target sits among peer trials
1,341 6th of 72 higher than 67 of 72 other Contraception trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Contraception trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Oral Contraceptive Pill (OCP) Pharmacogenomics
RECRUITING · Phase 4
-
Intravenous Ketorolac Administration to Attenuate Post-procedural Pain Associated With Intrauterine Device Placement
RECRUITING · Phase 4
-
Patient-clinical Linkages to Improve Trust and Engagement in Postpartum Healthcare
RECRUITING · NA
-
Empathy Through Pain Control: Lidocaine Paracervical Block for IUD Placements
RECRUITING · NA
-
Hormonal Contraception Access Through Pharmacist Prescribing Implementation
RECRUITING · NA
-
Prospective Multi-Center Trial for FemBloc Permanent Birth Control
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06731608 · 1,344 participants · NA
OsteoPorotic fracTure preventION System (OPTIONS) Research Study
- NCT06972056 · 1,335 participants · Phase 4
Comparative Effectiveness of Migraine Preventive Medications: The APT Comparison Study
- NCT06318169 · 1,350 participants · Phase 3
A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)
- NCT06605404 · 1,350 participants
Pan-tumor MRD Study
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI